NCT Number: NCT06150417
Phase: PHASE2
Trial Summary: The purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will help control disease better than the usual – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Case Comprehensive Cancer Center
Acronym:
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives